Live from the NIH registry
Studies recruiting near McKinney right now
Top 25 of 446 recruiting studies, sorted by proximity — each links to its official registry page
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Metroplex Pulmonary & Sleep Center — McKinney, Texas (3.0 mi)
· Sponsor: Philip Morris Products S.A.
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Baylor Scott & White Research Institute at The Heart Hospital Baylor Plano — Plano, Texas (12.7 mi)
· Sponsor: Biosense Webster, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Tekton Research — McKinney, Texas (3.0 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UT Southwestern Clinical Center at Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: SWOG Cancer Research Network
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
AIM Trials — Plano, Texas (12.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Texas Southwestern Simmons Cancer Center - Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: Pfizer
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Alliance Clinical Lewisville (Epic Clinical Research) — Lewisville, Texas (21.8 mi)
· Sponsor: Crystalys Therapeutics
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
North Dallas Research Associates — McKinney, Texas (3.0 mi)
· Sponsor: Baylor Research Institute
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Cardiomyopathies, Heart Failure
N/A
Interventional 300 participants sought
CardioVoyage — McKinney, Texas (3.0 mi)
· Sponsor: Zoll Medical Corporation
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clincal Site — Plano, Texas (12.7 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
The Heart Hospital Baylor Plano — Plano, Texas (12.7 mi)
· Sponsor: Edwards Lifesciences
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjögren, Sjogren Disease
Phase 1
Interventional 36 participants sought
Cullinan Investigative Site — Plano, Texas (12.7 mi)
· Sponsor: Cullinan Therapeutics Inc.
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Duchenne Muscular Dystrophy
Phase 3
Interventional 80 participants sought
Neurology Rare Disease Center — Flower Mound, Texas (28.0 mi)
· Sponsor: Solid Biosciences Inc.
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-054 — McKinney, Texas (3.0 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Primary Mitochondrial Disease
Phase 2
Interventional 180 participants sought
Neurology and Neuromuscular Care Center-Neurology Rare Disease Center — Flower Mound, Texas (28.0 mi)
· Sponsor: Pharming Technologies B.V.
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Dallas Nephrology Associates McKinney — McKinney, Texas (3.0 mi)
· Sponsor: Calliditas Therapeutics AB
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
Neurology Rare Disease Center — Denton, Texas (27.0 mi)
· Sponsor: Takeda
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Type 2 Diabetes
Phase 2
Interventional 60 participants sought
Epic Clinical Research — Lewisville, Texas (21.8 mi)
· Sponsor: Biomea Fusion Inc.
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
Benign or Malignant Pancreatic Diseases
N/A
Observational 500 participants sought
Trinity Surgical Consultants, Methodist Richardson Medical Center — Richardson, Texas (17.9 mi)
· Sponsor: Methodist Health System
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — McKinney, Texas (3.0 mi)
· Sponsor: AstraZeneca
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
Tricuspid Valve Regurgitation
N/A
Interventional 50 participants sought
Baylor Heart Hospital — Plano, Texas (12.7 mi)
· Sponsor: inQB8 Medical Technologies, LLC
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
UT Southwestern Clinical Center at Richardson/Plano — Richardson, Texas (17.9 mi)
· Sponsor: NRG Oncology
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Texas Oncology - Northeast Texas ( Site 8005) — Flower Mound, Texas (28.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Allen, Texas (6.8 mi)
· Sponsor: AstraZeneca
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Aortic Arch Aneurysm, Aortic Arch Dissection
N/A
Interventional 132 participants sought
Baylor Scott & White — Plano, Texas (12.7 mi)
· Sponsor: Artivion Inc.